Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers.
Press Releases
06 Jan 2020The Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 202424 Nov 2019The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 billion18 Nov 2019The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.